(Q34320961)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11475943%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11475943%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11475943%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Imbimbo BP

series ordinal

1

1 reference

1 August 2017

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11475943%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11475943%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11475943%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11475943%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

375-390

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11475943%20AND%20SRC:MED&resulttype=core&format=json

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study.

9 November 2019

cites work

1 reference

12 December 2020

Carbamate analogues of (-)-physostigmine: in vitro inhibition of acetyl- and butyrylcholinesterase

1 reference

12 December 2020

Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease

1 reference

12 December 2020

Metrifonate for Alzheimer's disease patients.

1 reference

12 December 2020

Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses

1 reference

12 December 2020

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

12 December 2020

Safety of tacrine: clinical trials, treatment IND, and postmarketing experience

1 reference

12 December 2020

Muscarinic receptors mediate attenuation of extracellular acetylcholine levels in rat cerebral cortex after cholinesterase inhibition

1 reference

12 December 2020

Pharmacokinetics of galanthamine in humans and corresponding cholinesterase inhibition.

1 reference

12 December 2020

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

12 December 2020

Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica

1 reference

12 December 2020

Cholinergic receptor interactions and their effects on long-term memory processing.

1 reference

12 December 2020

Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease

1 reference

12 December 2020

A 25-week placebo-controlled study of eptastigmine in patients with Alzheimer disease.

1 reference

12 December 2020

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

1 reference

12 December 2020

Cholinesterase inhibitors: A new class of psychotropic compounds

1 reference

12 December 2020

Effects of the novel compound NIK-247 on impairment of passive avoidance response in mice.

1 reference

12 December 2020

Sensitivity of bovine retinal acetylcholinesterase (E.C. 3.1.1.7) toward tacrine: kinetic characterization

1 reference

12 December 2020

Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution

1 reference

12 December 2020

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

1 reference

12 December 2020

Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's disease.

1 reference

12 December 2020

The pharmacological basis for metrifonate's favourable tolerability in the treatment of Alzheimer's disease.

1 reference

12 December 2020

A 6-month, double-blind, placebo-controlled trial of eptastigmine in Alzheimer's disease.

1 reference

12 December 2020

Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease.

1 reference

12 December 2020

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

12 December 2020

Structure and functions of acetylcholinesterase and butyrylcholinesterase

1 reference

12 December 2020

Butyrylcholinesterase‐rich neurons in rat brain demonstrated by a sensitive histochemical method

1 reference

12 December 2020

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group

1 reference

12 December 2020

Cholinesterase inhibition: complexities in interpretation.

1 reference

12 December 2020

The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5'butyrylcholinesterase-DNA study

1 reference

12 December 2020

Anticholinesterase activity of a new carbamate, heptylphysostigmine, in view of its use in patients with Alzheimer-type dementia.

1 reference

12 December 2020

Efficacy and safety of eptastigmine for the treatment of patients with Alzheimer's disease.

1 reference

12 December 2020

Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease

1 reference

12 December 2020

Non-cholinergic functions of acetylcholinesterase

1 reference

12 December 2020

Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease

1 reference

12 December 2020

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

1 reference

12 December 2020

Correlation between plasma physostigmine concentrations and percentage of acetylcholinesterase inhibition over time after controlled release of physostigmine in volunteer subjects

1 reference

12 December 2020

Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group.

1 reference

12 December 2020

Preferential cerebrospinal fluid acetylcholinesterase inhibition by rivastigmine in humans

1 reference

12 December 2020

Steady-state pharmacokinetics of tacrine in long-term treatment of Alzheimer patients.

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following evening administration

1 reference

12 December 2020

Inhibition of acetylcholinesterase from electric eel by (-)-and (+)-physostigmine and related compounds.

1 reference

12 December 2020

Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

1 reference

12 December 2020

Clinical pharmacokinetics of physostigmine in patients with Alzheimer's disease.

1 reference

12 December 2020

Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine

1 reference

12 December 2020

Central causes of dizziness.

1 reference

12 December 2020

An in vivo pharmacological study on muscarinic receptor subtypes regulating cholinergic neurotransmission in rat striatum

1 reference

12 December 2020

The recovery of cerebrospinal fluid acetylcholinesterase activity in Alzheimer's disease patients after treatment with metrifonate

1 reference

12 December 2020

Intestinal myoelectric activity after activation of central emetic mechanism.

1 reference

12 December 2020

Challenging the cholinergic hypothesis in Alzheimer disease.

1 reference

12 December 2020

Pharmacological evaluation of phenyl-carbamates as CNS-selective acetylcholinesterase inhibitors

1 reference

12 December 2020

Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos.

1 reference

12 December 2020

Autoregulation of acetylcholine release in isolated hippocampal nerve endings

1 reference

12 December 2020

An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors.

1 reference

12 December 2020

Comparison of butyrylcholinesterase and acetylcholinesterase

1 reference

12 December 2020

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

1 reference

12 December 2020

Relationship between pharmacokinetics and pharmacodynamics of eptastigmine in young healthy volunteers

1 reference

12 December 2020

Pressor and bradycardic effects of tacrine and other acetylcholinesterase inhibitors in the rat

1 reference

12 December 2020

Chronic effects of low level exposure to anticholinesterases--a mechanistic review

1 reference

12 December 2020

Cholinergic modulation of memory in rats

1 reference

12 December 2020

From molecular structure to Alzheimer therapy

1 reference

12 December 2020

Intent-to-treat analysis for longitudinal studies with drop-outs.

1 reference

12 December 2020

Characterization of a novel muscarinic receptor agonist, YM796: comparison with cholinesterase inhibitors in in vivo pharmacological studies

1 reference

12 December 2020

Acetylcholinesterase (AChE) (EC 3.1.1.7.)

1 reference

12 December 2020

Butyrylcholinesterase in the life cycle of amyloid plaques

1 reference

12 December 2020

Possible association between donepezil and worsening Parkinson's disease

1 reference

12 December 2020

Noxious stimulation of emesis.

1 reference

12 December 2020

Urinary incontinence: an unrecognised adverse effect with donepezil.

1 reference

12 December 2020

Clinical Pharmacokinetics of Tacrine

1 reference

12 December 2020

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group

1 reference

12 December 2020

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

1 reference

12 December 2020

Aricept-induced nightmares in Alzheimer's disease: 2 case reports.

1 reference

12 December 2020

Cholinergic drugs reverse AF64A-induced impairment of passive avoidance learning in rats.

1 reference

12 December 2020

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

1 reference

12 December 2020

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

12 December 2020

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

12 December 2020

Clinical heterogeneity: responders to cholinergic therapy

1 reference

12 December 2020

A new rating scale for Alzheimer's disease.

1 reference

12 December 2020

A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer's disease

1 reference

12 December 2020

Purpuric rash with donepezil treatment

1 reference

12 December 2020

10.2165/00023210-200115050-00004

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11475943%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 November 2019

1010410159

0 references

1 reference